ClinicalTrials.gg
Sign In

Sarcopenia clinical trials

The registry lists 1,329 studies for Sarcopenia across more than 10 countries. 420 are recruiting or about to start. 798 of them are mainly about Sarcopenia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 1,431 studies for Sarcopenia. How that becomes 1,329 here

This page counts the studies the registry files under Sarcopenia, and those it files under no condition that list Sarcopeniathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,431Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −17List Sarcopenia as a condition, but the registry did not file them under itMost often written as “Sarcopenia in Elderly” (8), “Age-Related Sarcopenia” (7), and “Pre-sarcopenia” (1). The registry filed them under other conditions only, most often Frailty (5) and Motor Activity (3).
  3. −85Match it another way84 name it in the title and 1 in a keyword.
  4. 1,329The count on this page23 of them list Sarcopenia in their own words; the registry filed them under no condition.

Get an email when these change. Save the Sarcopenia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
628
Recruiting
247
Status unknown
158
Not yet recruiting
144
Active, not recruiting
66
Terminated
36

Phase

Phase 2
52
Phase 3
26
Phase 4
21
Phase 1
21
Early Phase 1
9

Where

United States
187
Turkey
130
Spain
99
Taiwan
96
China
81
France
78

Who runs them

National Taiwan University Hospital (22) · Maastricht University Medical Center (17) · Chang Gung Memorial Hospital (14) · University of Nottingham (14) · University Hospital, Clermont-Ferrand (12) · Bispebjerg Hospital (12) · The University of Texas Medical Branch, Galveston (10) · Istanbul Physical Medicine Rehabilitation Training and Research Hospital (9)

What is being tested here

Drugs under test in Sarcopenia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Whey Proteins5014
Creatine419
Creatine monohydrate318
Whey Protein Isolate304
Omega-3 fatty acid209
Vitamin D217
Amino Acids, Branched-Chain216
Protein Supplement204
Soybean Proteins204
Valine202

Drug classes tested here Androgens 2 open

Coming up

8phase 3 studies under way
149studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 247 Sarcopenia studies recruiting now, 153 (62%) set no upper age limit and 33 (13%) stop at 75 or younger. 9 (4%) take children under 18. 10 (4%) are for women only and 5 (2%) for men only; 65 (26%) take healthy volunteers.

Recruiting studies that take each age, of 247
AgeWomenMen
108 (3%)8 (3%)
18110 (45%)106 (43%)
30125 (51%)121 (49%)
40138 (56%)135 (55%)
50161 (65%)156 (63%)
65225 (91%)219 (89%)
75219 (89%)215 (87%)
85188 (76%)185 (75%)

Across all 1,329 studies, recruiting or not: 16% stop at 75 or younger and 7% at 65; 3% take children; 7% are for women only and 6% for men only; 41% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Sarcopenia studies take

Of 20 phase 2 interventional studies under Sarcopenia, half reached primary completion within 37 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 237 mo19–39 · 20 studies——
Interventional, no phase18 mo8–34 · 503 studies—18 mo8–34 · 492 studies
Observational26 mo12–63 · 194 studies—26 mo12–63 · 192 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting3

Results posted1

Newly registered24

Show 19 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,329. Browse all 1,329 → or search them.